Allergy Treatment: A Comprehensive Review of Nanoparticle-based Allergen Immunotherapy
Frontiers in Bioscience-Landmark · 20.03.2025 · 30 (3)
DOI: 10.31083/fbl26550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 20.03.2025. Verfasst von Mabrouk A Abo-Zaid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Jazan University, P.O. Box. 114, 45142 Jazan, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Nanoparticles, Hypersensitivity, Allergens. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Allergic disorders rising in prevalence globally, affecting a substantial proportion of individuals in industrialized nations. The imbalance in the immune system, characterized by elevated allergen-specific T helper 2 (Th2) cells and immunoglobulin E (IgE) antibodies, is a key factor in allergy development. Allergen-specific immunotherapy (AIT) is the only treatment capable of alleviating allergic symptoms, preventing new sensitizations, and reducing asthma risk in allergic rhinitis patients. Traditional AIT, however, faces challenges such as frequent administration, adverse effects, and inconsistent patient outcomes. Nanoparticle-based approaches have emerged as a promising strategy to enhance AIT. This review explores the utilization of nanoparticles in AIT, highlighting their ability to interact with the immune system and improve therapeutic outcomes. Various types of nanoparticles, including polyesters, polysaccharide polymers, liposomes, protamine-based nanoparticles (NPs), and polyanhydrides, have been employed as adjuvants or carriers to enhance AIT’s efficacy and safety. Nanoparticles offer advantages such as allergen protection, improved immune response modulation, targeted cell delivery, and reduced side effects. This review provides an overview of the current landscape of nanoparticle-based allergen immunotherapy, discussing its potential to revolutionize allergy treatment compared to traditional immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, Jazan University, P.O. Box. 114, 45142 Jazan, Kingdom of Saudi Arabia.
- Faculty of Pharmacy, Cairo University, 12613 Cairo, Egypt.
- Biotechnology Department, Faculty of Science, Cairo University, 12613 Giza, Egypt.
- Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, 45142 Jazan, Kingdom of Saudi Arabia.
Zitieren
APA
Abo-Zaid, M. A., Elsapagh, R. M., Sultan, N. S., Mawkili, W., Hegazy, M. M., & Ismail, A. H. (2025). Allergy Treatment: A Comprehensive Review of Nanoparticle-based Allergen Immunotherapy. Frontiers in Bioscience-Landmark, 30(3). https://doi.org/10.31083/fbl26550
Vancouver
Abo-Zaid MA, Elsapagh RM, Sultan NS, Mawkili W, Hegazy MM, Ismail AH. Allergy Treatment: A Comprehensive Review of Nanoparticle-based Allergen Immunotherapy. Frontiers in Bioscience-Landmark. 2025;30(3). doi:10.31083/fbl26550
BibTeX
@article{AboZaid2025,
author = {Abo-Zaid, Mabrouk A and Elsapagh, Reem M and Sultan, Nourhan S and Mawkili, Wedad and Hegazy, Maysa M and Ismail, Ahmed H},
title = {Allergy Treatment: A Comprehensive Review of Nanoparticle-based Allergen Immunotherapy},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {3},
doi = {10.31083/fbl26550}
}
EUVIMED